Malignant Tumor
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Pathologically confirmed malignant tumor; (2) At least one measurable lesion present; (3) Scheduled to receive immunotherapy (either as monotherapy or in combination with chemotherapy); (4) No prior history of immunotherapy; (5) No gender restrictions, aged 18 to 75 years (inclusive).
Exclusion criteria
Exclusion criteria: (1) Patients unsuitable for immunotherapy; (2) Patients unable or unwilling to provide written informed consent; (3) Patients with mobility impairments or those unable to lie flat for 30 minutes during examination; (4) Patients who are planning pregnancy, currently pregnant, or breastfeeding; (5) Patients with claustrophobia; (6) Severe liver or renal failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax;SUVmean;Sensitivity;Specificity;Accuracy;Tumour-to-mediastinum ratio; | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive predicative value;Negative predictive value; | — |
Countries
China
Contacts
The First Affiliated Hospital of Chongqing Medical University